Your browser doesn't support javascript.
loading
A dual TLR agonist adjuvant enhances the immunogenicity and protective efficacy of the tuberculosis vaccine antigen ID93.
Orr, Mark T; Beebe, Elyse A; Hudson, Thomas E; Moon, James J; Fox, Christopher B; Reed, Steven G; Coler, Rhea N.
Afiliación
  • Orr MT; Infectious Disease Research Institute, Seattle, Washington, United States of America.
  • Beebe EA; Infectious Disease Research Institute, Seattle, Washington, United States of America.
  • Hudson TE; Infectious Disease Research Institute, Seattle, Washington, United States of America.
  • Moon JJ; Center for Immunology and Inflammatory Diseases and Pulmonary and Critical Care Unit, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts, United States of America.
  • Fox CB; Infectious Disease Research Institute, Seattle, Washington, United States of America.
  • Reed SG; Infectious Disease Research Institute, Seattle, Washington, United States of America.
  • Coler RN; Infectious Disease Research Institute, Seattle, Washington, United States of America ; Department of Global Health, University of Washington, Seattle, Washington, United States of America.
PLoS One ; 9(1): e83884, 2014.
Article en En | MEDLINE | ID: mdl-24404140

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Tuberculosis / Adyuvantes Inmunológicos / Vacunas contra la Tuberculosis / Receptores Toll-Like / Mycobacterium tuberculosis Límite: Animals Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2014 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Tuberculosis / Adyuvantes Inmunológicos / Vacunas contra la Tuberculosis / Receptores Toll-Like / Mycobacterium tuberculosis Límite: Animals Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2014 Tipo del documento: Article País de afiliación: Estados Unidos